According to filings with the U.S. Securities and Exchange Commission, Avava is raising up to $37,978,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Avava
AVAVA bends the laws of physics transforming light, heat, and energy delivery. Standing on the shoulders of giants, were shaping the future of our industry. Our Focal Point Technology has pioneered energy disbursement like never before. Skin, the largest organ of your body, does more than protect. It heals, feels, and communicates for your entire being. AVAVA is the connective tissue delivering energy for the benefit of everyone. Boundless Energy. Fearless Vision.

To learn more about Avava, visit https://avavaskin.com/
Avava Linkedin Page: https://www.linkedin.com/company/avavaaskin/

Contact:
Clinton Carnel, Chief Executive Officer
617-912-2680

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.